Evidence map

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2018

Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.

Lars Wilkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29557057